Mefitel film for radiation dermatitis: it works, why not?

Published Date: 13 Mar 2023

According to the results of a phase 3 trial, the use of silicone film before radiotherapy can reduce the incidence of radiodermatitis, so why not use it?

Read Full News

Latest News

10-Year Data Back Early Start to Biologics in Arthritic Diseases

— Sustained drug-free remission common in spondyloarthritis patients treated with golimumab

Shingles Recurrence or Something Worse?

Bedside skin punch biopsy proved crucial

Skin Problems, Kidney Complaints, and Venous Issues Spike During Heat Waves

Study suggests attention to heat-related problems besides heat stroke

First Oral Option for Dermatomyositis Gets FDA Green Light

Brepocitinib significantly improved overall symptom status in a phase III trial

A Call to End Routine Laboratory Monitoring for Patients on Isotretinoin

Streamlined testing still overkill given lack of evidence for hepatotoxicity, pancreatitis

Risk of Paradoxical Hidradenitis Suppurativa in Psoriasis Varies by Biologic Agent

Infliximab and adalimumab had the highest risk, risankizumab and guselkumab the lowest

Todays Updates

ASTRO: American Society for Radiation Oncology

Todays Updates

ASTRO: American Society for Radiation Oncology

Latest News

— Sustained drug-free remission common in spondyloarthritis patients treated with golimumab

Bedside skin punch biopsy proved crucial

Study suggests attention to heat-related problems besides heat stroke

Brepocitinib significantly improved overall symptom status in a phase III trial

Streamlined testing still overkill given lack of evidence for hepatotoxicity, pancreatitis

Infliximab and adalimumab had the highest risk, risankizumab and guselkumab the lowest

News All Time

US Regulators Urge More Research on Testosterone Therapy for Women as Experts Debate Benefits, Risks

US health regulators on Thursday called for more data on testosterone therapies for women, with FDA officials urging manufacturers to conduct studies that could support...

FDA Grants Priority Review for Diabetic Foot Ulcer Therapy

The FDA has granted priority review for a novel wound-healing therapy for Wagner Grade 1 diabetic foot ulcers.

Fear of Relapse Burdens Patients With Vitiligo

Nearly half of patients with vitiligo who achieve repigmentation fear losing treatment gains, with relapse-related anxiety affecting psychological well-being even when skin improvement is maintained.

Adding IVIG to Prednisone Boosts Outcomes in IIMs

IVIG plus high-dose prednisone leads to improved disease activity and a faster response in newly diagnosed idiopathic inflammatory myopathies, but clotting remains a concern.

Smoke Exposure Tied to HS Risk in Children and Teens

Both passive and active exposure were associated with increased odds of diagnosis in pediatric and adolescent patients with hidradenitis suppurativa, a study reports.

Pennsylvania Measles-associated Deaths Climb to Four as Outbreak Grows

The Pennsylvania Department of Health on Tuesday reported two more measles-associated deaths, both in unvaccinated individuals, bringing the state's total fatalities linked...

A Decade After Mercury Ban, Toxic Skin Bleachers Still Offered on Top Retailers' Websites

(Removes errant quote marks in paragraph 14)

FDA Grants Priority Review to Zasocitinib for Psoriasis

Zasocitinib is also being evaluated in phase 3 studies for psoriatic arthritis and in phase 2 studies for Crohn’s disease, ulcerative colitis, vitiligo, and hidradenitis suppurativa.

Serious Infections Lower With Anifrolumab in CLE Patients

Anifrolumab, approved for systemic lupus, is currently being evaluated in a phase 3 study in patients with cutaneous lupus erythematosus.

COVID, 6 Years on: The Pandemic’s Long Clinical Shadow

Although acute COVID is generally less severe today, long COVID, limited treatment options, and ongoing controversy still define the pandemic’s aftermath.

Trust in Measles Vaccines Falls in US, Reuters Ipsos Poll Finds

Americans' trust in vaccines for deadly childhood diseases including measles has fallen in recent years, a new Reuters/Ipsos poll found, a troubling sign for the country as...

Prior Keratinocyte Carcinoma Tied to Mucosal Melanoma

A history of keratinocyte carcinoma was associated with more than four times the odds of mucosal melanoma, study reports.

Arizona Accuses L'Oreal Of Concealing Cancer Risks Linked to Hair Relaxers

Arizona has sued L'Oreal SA and its U.S. subsidiary, alleging the cosmetics company hid evidence that its hair relaxer products could cause cancer ⁠in women, as it faces...

Pembrolizumab Benefits Persist in Cervical Cancer

After 5 years of follow-up, pembrolizumab plus chemotherapy continues to demonstrate sustained survival advantages in patients with persistent, recurrent, or metastatic cervical cancer.

Criteria for Prescribing Testosterone: Who Qualifies?

A Brazilian multidisciplinary consensus sets thresholds for the diagnosis and treatment while emphasizing symptom assessment, repeated testing, and attention to the underlying causes.

Combo Therapy May Help in Systemic Autoinflammatory Diseases

Patients with systemic autoinflammatory diseases refractory to standard treatments may show clinical improvements when treated with combinations of biologics and JAK inhibitors.

Recommended News For You

Review looks at potential treatment targets in the tumor microenvironment.

Tumor-targeting fluorescent bacteria illuminate cancer for precision surgery

Active Surveillance Lawsuits; More Eligibility for Studies; Biosimilars Make News.

Adjuvant ICIs: A Winner and a Loser in Clear Cell Renal Cell Carcinoma?

How AI will transform mental health support for patients with breast cancer

A single bout of exercise gives results that could help cancer patients

Subcutaneous Cancer Immunotherapies Provide New Options for Physicians and Patients

Recommended Articles For You

Environmental Carcinogen Exposure Screening: Advances, Clinical Implications, and Guideline-Based Approaches 

Can Wearables and AI Become a Gamechanger for Histiocytic Cancer Detection? 

Recent Advances in Hematology 

Molecular Mechanisms of Tumor Extracellular-Matrix Stiffness Sensing 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Despite Medicare Coverage, Cancer Genomic Testing Still Low

2.

VP Nominee Medical Records Breached; Queen Elizabeth's Cancer; Galaxy Gas Whippets

3.

PRO Data Strengthen Case for Dato-DXd in First-Line TNBC

4.

In a recent study, Kencur ginger's anti-cancer properties were discovered.

5.

Does Telenursing Improve QOL in Breast Cancer?

1.

Spatial Transcriptomics in Oncology: Transforming Tumor Biology and Precision Medicine

2.

Unlocking the Potential of SABCS 2022: Innovative Strategies for Cancer Research

3.

Understanding Mantle Cell Lymphoma Prognosis.

4.

Liquid Biopsy in Hematologic Malignancies: Current Evidence and Clinical Applications

5.

Unlocking the Power of Neutrophils: Harnessing Their Disease-Fighting Potential

1.

International Cancer Conference

2.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

1.

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part IV

2.

Lung Cancer: Risk Factors and Prevention

3.

Efficient Management of First line ALK-rearranged NSCLC - Part III

4.

Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)

5.

Optimizing Treatment Options in Advanced Urothelial Carcinoma

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot